Fro. I. Proteins purified from rabbit plasma (used in these studies) analyzed by SDS-PAGE in the presence (R) and absence (NR) of ~-mercaptoethanol. Zymogen HF is a single polypeptide chain of 82,000 M,. HFa (enzyme) is dissociated into fragments of 52,000 and 28,000 M, in the presence of reducing agents. Residual native HF remains at 82,000 M~ in the presence of reducing agents. PK zymogen is a single polypeptide chain of 85,000 M,. Upon activation to kallikrein, the single polypeptide chain is cleaved into fragments of 55,000 and 35,000 Mr. High-M~ kininogen is a single polypeptide chain of 100,000 Mr in the presence and absence of reducing agents. Rabbit C5 is a two-chain disulfide-linked molecule of unreduced 180,000 Mr, which dissociates into chains of 130,000 and 85,000 Mr in the presence of reducing agent. HF, PK and high-Mr kininogen are shown here on 7.5% SDS gels, whereas C5 is shown as a 5% SDS gel.
goat-anti-rabbit PK was prepared by: (a) absorption of plasma with kaolin (25 mg kaolin/ml) incubated for 10 rain at 37°C and then centrifuged for 15 rain at 5,000 g to remove the kaolin; (b) dialysis of the kaolin-absorbed serum against 0.01 M phosphate buffer, pH 7.7, followed by absorption in batches using DEAE-cellulose (10 g/g protein) equilibrated in the above buffer; (c) concentration of the globulin fraction by precipitation with 50% ammonium sulfate and subsequent dialysis against 0.1 M phosphate buffer, pH 7.5. The IgG fraction thus produced contained no detectable goat kallikrein (<20 ng/ml), as measured by the chromogenic tripeptide assay.
This IgG fraction in 0.1 M phosphate buffer, pH 7.5, was coupled to cyanogen bromideactivated Sepharose-4B (5) at a ratio of 5 mg of protein/1 g of Sepharose-4B. The washed beads were incubated overnight at +4°C with 5 mM diisopropyi fluorophosphate in water. The beads were rewashed and poured into a 2.5-X 30-cm plastic column to a bed height of 26 cm. The column was washed with 5 M guanidine, followed by 0.1 M Tris buffer, pH 7.4, containing 1 M NaCI, 20 mM EDTA, 10 mM benzamidine, 0.05% hexadimethrene bromide (Polybrene; Aldrich Chemical Co., Inc., Milwaukee, Wis.) and 0.02% sodium azide.
Citrated normal rabbit plasma (200 ml) was made 10 mM with benzamidine, 0.7 M with NaCI, 20 mM EDTA, 0.05% Polybrene, and 0.02% sodium azide. The plasma was run through the column at room temperature at a flow rate of 100 ml/h~ The column was washed with 10-column volumes of starting buffer and then eluted with 5 M guanidine (Sigma Chemical Co., St. Louis, Mo.). The fractions calculated to contain the initial guanidine step and one-column volume thereafter were pooled for the second step.
Step 2. Ion-Exchange Chromatography on SP-Sephadex C-50. The pool from Step 1 (200 ml) was dialyzed against 0.1 M acetate buffer, pH 5.3, containing 0.04 M NaCl, 2 mM EDTA, 1 mM benzamidine, 0.05% Polybrene, and 0.02% sodium azide. 2 g of SP-Sephadex C50 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) hydrated overnight in the above buffer was poured into a siliconized 2.5-X 30-cm column. After two changes of dialysis, the pool was loaded at 40 ml/h. The column was washed with four-column volumes of starting buffer. A step elution was effected with 0.1 M acetate buffer, pH 5.3, containing 0.35 M NaC1 (= 40 mS).
Step 3. Affinity Chromatography on Concanavalin A-Sepharose. The pooled fractions containing PK (40 ml) were dialyzed against 0.1 M sodium phosphate buffer, pH 7.5, containing 1 M NaC1, 0.02% sodium azide, and 1 mM benzamidine. The dialyzed material was loaded at 3 ml/h onto a 1.7-cm diameter siliconized glass column containing 6 ml of concanavalin-A Sepharose. The column was washed with 60 mi of the above buffer. Elution of PK was effected with the above buffer containing 0.5 M a-D-methyl glucoside at 2 ml/h. Analysis of the eluted protein from the above column by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under both reducing and nonreducing conditions showed a single protein band with a molecular weight (Mr) of 83,000 (Fi~. 1). Assays of PK were performed by immunodiffusion, using goat anti-rabbit PK antiserum.
KALLXKREIN OENrRATIO~. Kallikrein wa:~ generated by incubating PK with a-HFa in the following manner. PK (1 ml, 220 #g) was incubated with a-HFa (50 #l, 10 #g) in the presence of 10 #1 2 M Tris buffer, pH 8.0, for 60 min at 37°C. The HFa was not removed from the kallikrein preparation, but constituted <1% of the protein present. The extent of proteolytic cleavage of prekallikrein as measured by SDS-PAGE ( Fig. 1) varied between 58 and 94% in different preparations. The enzymatic activity of kallikrein in each preparation was measured colorimetrically using the tripeptide suhstrate N-Benzoyl-L-Pro-l:phe-L-arginine-p-nitroanalide (Bz-pro-phe-arg-pNA; Vega Biochemicals, Tucson, Ariz.) under the conditions described below. The calculated I~,t value obtained for different preparations varied between 300 and 400 rain -I. The PK purified in this manner showed a line of identity with rabbit PK purified by ion-exchange chromatography (6) and generously donated by Dr. Richard Ulevitch of the Research Institute of Scripps Clinic. HIOH-Mr KmINOOEN. High-Mr kininogen was purified from rabbit plasma by a three-step procedure.
Step I. Solid-Phase Immunoabsorption of High-Mr Kininogen from Rabbit Plasma. Goat antirabbit high-Mr kininogen was coupled to Sepharose 4B as described for PK. Citrated normal rabbit plasma was passed over an anti-high-Mr kininogen-Sepharose 4B column and eluted with 5 M guanidine as described above.
Step 2. DEAE-Sephadex A50 Ion-Exchange Chromatography. The pool from Step 1 (500 ml) was dialyzed against buffer containing 0.4 M Tris, 0.1 M succinic acid, pH 8.2, containing 40 mM NaCI, 10 mM benzamidine, 2 mM EDTA, and 0.02% sodium azide. This material was loaded onto a 2.5-× 30-era siliconized column containing 3 g of DEAE-Sephadex AS0 equilibrated in the starting buffer. The column was washed with five-column volumes of starting buffer and eluted with a gradient consisting of 150 ml of the starting buffer in the proximal chamber and 150 ml of 0.3 M Tris, 0.12 M suecinic acid, pH 7.4, containing 0.3 M NaCI, 2 mM EDTA, 10 mM benzamidine, and 0.02% sodium azide. The high-Mr kininogen eluted in the distal shoulder of the protein peak, whereas low-M, kininogen eluted in the proximal shoulder of the peak.
Step 3. SP-Sephadex Ion-Exchange Chromatography. The pool containing high-Mr kininogen from Step 2 (70 ml) was dialyzed against 0.1 M acetate buffer, pH 5.3, containing 75 mM NaCI, 10 mM benzamidine, 2 mM EDTA, and 0.02% sodium azide. This material was loaded onto 2 g SP-Sephadex C50 equilibrated in the above buffer. The column was washed with 10-column volumes of the above buffer with the NaCI increased to 60 mM, and the high-Mr kininogen was then eluted with a salt gradient to 0.4 M NaCI in 0.1 M acetate buffer, pH 5.3. The eluted material analyzed by SDS-PAGE in the presence and absence of reducing agents revealed a single predominant protein band with an Mr of 100,000 (Fig. 1) . This material had a specific clotting activity of 6.5 clotting U/rag, where 1 U is the amount of rabbit high-Mr kininogen present in 1 ml of plasma when assayed in human high-Mr kininogen-deficient (Fitzgerald) plasma.
C5. C5 was purified from normal rabbit plasma by euglobulin precipitation (pH 5.0), and ion-exchange and gel-filtration chromatography as previously described (7) . Rabbit C5 thus prepared was homogeneous on SDS-PAGE ( Fig. 1 ) and contained no detectable C3 by functiona_~l or immunoehemical analysis.
EAC423 Preparation.
Sheep erythrocytes bearing the classical pathway C5 eonvertase were prepared from human complement components by the method of Rapp and Borsos (8) .
Chromogenic Tripeptide Assay. The synthetic ehromogenic tripeptide Bz-pro-phe-arg-pNA HC1 was dissolved in 0.1 M Tris, pH 8.3, containing 0.05 NaCI and 0.02% sodium azide at a final concentration of 0.1 mg/ml. The sample to be assayed (2-5 #1) was added to a 300-/LI volume of substrate in a cuvette and the change in absorbance was measured at 405 nM. The GHEMOTACTIC ACTIVITY GENERATED BY PLASMA KALLIKREIN values for K~at were calculated using a molar extinction coefficient of 10,000 M -x cm -~ at 405 nM.
Neutrophil Function Assays. These were performed using leukocytes isolated from New Zealand White rabbits as previously described (9) . The modified Boyden assay was performed using the two-filter technique of Keller et al. (10) . The leading front method was performed according to Zigmond and Hirsch (11) . Each sample was measured in triplicate and the results were expressed as the mean :t: 1 SD from the mean. For each assay positive (5% zymosan-activated rabbit serum [ZARS] and negative (Hanks' balanced salt solution-bovine serum albumin [HBSS-BSA]) controls were incorporated. The Keller assay and leading front assays were sensitive to 5 ng and 0.2 ng of human G5a, respectively (9).
Kinin Bioassay. This was performed using the estrogen-sensitized rat uterus assay as previously described (12) .
SDS-PAGE.
Analysis by SDS-PAGE was performed using cylindrical gels and the WeberOsborne system (13) . Gels were stained for protein with Goomassie Blue dye or cut into 1.2-ram slices and counted for 1~nI on an automated T-counter (Searle Radiographics, Inc., Des Plaines, Ill.).
Miscellaneous. Protein determinations were performed by the method of Lowry et al. (14) using BSA (5 times recrystallized; Reheis Chemical Co., Chicago, Ill.) as a standard. Radiolabeling was performed with 125I using the chioramine T method (15) . Neutrophil enzyme release was measured as described in reference 16.
Results
Chemotactic Activity Generated from C5 by Plasma Kallikrem. When rabbit C5 was incubated with rabbit plasma kallikrein, chemotactic activity could easily be demonstrated (Table I ). In contrast, no chemotactic activity could be demonstrated when the zymogen PK was tested with C5 under identical conditions. Chemotactic activity was also generated when rabbit C5 was incubated with a-HFa, trypsin, (Table I) , or EAC423. No chemotaetic activity was produced when C5 was absent from the incubation mixtures, or when intact C5 alone was assayed.
Direct Chemotactic Effect of Plasma Kallikrein. Because plasma kallikrein has been
reported to be directly chemotactic for neutrophils (4), we investigated the ability of rabbit plasma kallikrein alone to attract rabbit neutrophils. As shown in Table II , over a dose-range from 2.5 × 10-7-10 -l° M kallikrein, no detectable chemotactic Chemotactic activit~as generated when kallikrein (1.4 pg), a-HFa (2.4/~g), trypsin (0.2/zg), and EAC423 cells (1 x 107) were incubated with C5 (10 gg). All incubations were for 20 min at 37°C with the exception of trypsin, which was for 2 min at 22°C. The reaction was stopped with SBTI (40 pg) added for 5 min at 22°C. ZARS (5%) was used as a positive control. Each assay was performed in triplicate. * High power field. Plasma kallikrein at the above concentrations was tested for chemotactic activity in the presence of HBSS containing BSA (20 mg/ml) by both the modified Boyden assay and the leading front method (n = 3). * High power field. activity was observed using the modified Boyden chamber (see Materials and Methods). This was found consistently in four experiments using two different kallikrein preparations. Furthermore, using the more sensitive leading front method (see Materials and Methods), again, no chemotactic activity could be detected (Table II) in two experiments.
Enzymatic Activity of the Rabbit Plasma Kallikrein
To confirm that the kallikrein used in these experiments was biologically active, the following assays were performed.
TRIPEm'm~. HYDROLYSIS. The rate of hydrolysis of the synthetic substrate Bz-prophe-arg-pNA was measured spectrophotometrically. The calculated K~t value ranged from 300 to 460 rain -x under the conditions of assay (see Materials and Methods).
PROTEOLe'rlc CLEAVAGe OF m',DIOLAneLED SUSSTRATeS. The ability of the kallikrein to cleave its natural substrates, HF and high-Mr kininogen, was measured, x25I-HF (200 #g, 0.2 #Ci) or a25I high-Mr kininogen (250 #g, 0.2 #Ci) were incubated with dilutions of kallikrein and PK in the presence of 0.1 M Tris, pH 7.4, and BSA (1 mg/ ml). Typical cleavage patterns are shown in Fig. 2 , where 12SI-HF was cleaved into fragments of 28,000 and 50,000 Mr, and 12sI high-Mr kininogen was cleaved to one major fragment containing 12hi with an Mr of 70,000.
KINtN OEN~TmN. The ability of kallikrein to release biologically active kinin from rabbit high-Mr-kininogen was measured using an estrogen-sensitized rat uterus bioassay system (Table III) .
As confirmed by these studies, the kallikrein was capable of releasing biologically active kinin from high-Mr kininogen in association with proteolytic cleavage of the molecule. In contrast, PK did not cleave high-Mr kininogen and did not generate kinin. However, if a-HFa was incubated with PK, the PK was activated with subsequent release of kinin from high-Mr kininogen. We conclude that all the proteins used in these studies were capable of biological activity and that the kallikrein preparation was indeed kallikrein. 
Chemotactic Effect of HF and

NR <4
Purified proteins of the rabbit HF system were incubated together for 10 min at 37°C in the presence of 0.05 M Tris buffer containing BSA (1 mg/ml) in a total volume of 80/~1. 100/~1 of hot (100°C) saline was added to each tube and the samples were boiled for 4 min before the assay using an isolated estrogen-sensitized rat uterus (see Materials and Methods). NR, no response.
have any chemotactic activity, the natural kallikrein substrates in their activated form (a-HFa and kinin-free high-Mr kininogen) were tested for their ability to attract cells. a-HFa, the two-chain, 80,000-Mr form of activated HF, was tested over a dose range of 7 × 10-7-7 × 10 -t° M using the Boyden assay system. No chemotactic activity was observed (data not shown). Rabbit high-Mr kininogen (220 #g) was preincubated with rabbit kallikrein (20 #g) for 30 min at 37°C in the presence of 0.1 M Tris, pH 7.4. No chemotactic activity could be detected in this incubation mixture over a dose range of 2.5 × 10-7-2.5 X 10 -x° M high-Mr kininogen (data not shown).
We conclude that neither kallikrein nor HFa nor high-Mr kininogen is capable of attracting rabbit neutrophils under the conditions of study.
Finally, PK (40 #g/ml), HF (22 #g/ml), a-HFa (3 #g/ml), and high-Mr kininogen (55 #g/ml) were incubated together for 20 min at 37°C in the presence of BSA (1 mg/ml). Activation of protein was confirmed by measurement of kinin generation by bioassay. No chemotactic activity could be demonstrated using the Boyden method. We conclude that no detectable chemotactic fragments were generated during activation of these proteins.
Dose-Response Curve of Generation of Chemotactic Activity from C5 by Kallikrein.
A doseresponse curve of rabbit plasma kallikrein incubated with rabbit C5 (at a final concentration of 100 #g/ml) demonstrated the production of chemotactic activity by kallikrein down to a level of ~ 1 #g/ml (Fig. 3) (the physiological concentration of PK in rabbit plasmas is ~25 #g/ml). Thus, plasma kallikrein at physiological concentration appears to be capable of generating chemotactic activity from C5.
As indicated in Table I , a-HFa also generated chemotactic activity from C5. A dose-response curve for a-HFa indicated that a-HFa was about one-third as active as kallikrein in this respect.
Kallikrein-blocking Studies. To establish whether the kallikrein effect on C5 could be due to a contaminating enzyme, blocking studies were performed with anti-kallikrein IgG and with soybean trypsin inhibitor (SBTI). Rabbit kallikrein (20 #g/ml) was incubated with anti-PK or anti-HF antisera at a final concentration of 8 mg/ml for 20 min at 22°C in the presence of 0.1 M Tris buffer, pH 7.4. The kallikrein preparations were then assessed for their ability to (a) hydrolyse Bz-pro-phe-arg-pNA; (b) generate kinin from purified high-Mr kininogen as measured by the rat uterus bioassay; and (c) generate chemotactic activity from C5. For each assay system, the amount of the kallikrein-anti-HF preparation (control) used was on the upper portion of the dose-response curve. The response of the kallikrein-anti-PK preparation was compared with this value and expressed as the percent of the control. As shown in Fig. 4 , the anti-PK IgG blocked the tripeptide hydrolysis response by only 26%, whereas the chemotaxis and kinin generation responses were blocked by 41 and 68%, respectively. This difference in blocking effect by antibody was reproducible and was not effected by changing the ratio of kallikrein to anti-PK. It probably reflects greater steric hindrance by the anti-PK IgG-kallikrein complex for the larger substrates and possibly the requirement for two clips to liberate kinin from kininogen.
Kallikrein (5 #g) was also incubated with various doses of STBI (2.9, 1.5, and 0.7 #g) to generate inactive SBTI-kallikrein complexes in varying proportions such that ~xA, ½, and a~ of the kallikrein molecules would remain active. These partially inhibited kallikrein preparations were compared with a noninhibited control for their ability to (a) hydrolyse the tripeptide Bz-pro-phe-arg-pNA; (b) generate bradykinin from purified high-Mr kininogen; and (c) generate a chemotactic response from C5. As shown in Fig. 5 , the ability of SBTI to inhibit kallikrein activity on three different substrates was similar, indicating that the kallikrein-induced chemotactic response was due to kallikrein itself and not due to a contaminating enzyme.
Nature of the Chemotactic Substance Generated from C5 by Kallikrein
SECRETION OF •-GLUCURONIDASE FROM NEUTROPHILS. C5a is capable of causing specific release of granular contents from cytochalasin B-treated neutrophils (9) . To determine whether kallikrein-treated C5 generated a fragment capable of causing specific release as well as chemotaxis, the following experiment was performed.
Isolated rabbit neutrophils were suspended in HBSS in the presence of BSA (0.25%). Aliquots containing 4 X l06 neutrophils were incubated for 5 min at 37°C with cytochalasin B (5/lg/ml prepared at 5 mg/ml in dimethyl sulfoxide). The cells were then exposed to C5 (25 #g), which had been preincubated for 120 min at 37°C either with buffer, kallikrein (550 ng), EAC423 (5 × 107 cells), or trypsin (300 ng), after which SBTI (1 #g) was added to each incubation mixture and allowed to stand for 5 min at 22°C. Purified human C5a (15 ng) (generously donated by Robert O. Webster, National Jewish Hospital and Research Center, Denver, Colo.) was used as a positive control. The release of a granular enzyme,/~-glucuronidase, and a cytosol enzyme, lactic dehydrogenase (LDH), was measured as previously described (16, 17) after 30 rain incubation with the stimulus. No significant release of LDH occurred (<5% of total releasable by detergent), indicating that no cell lysis had occurred. The base-line release of~8-glucuronidase with C5 alone after 120 rain at 37°C was 9.8% of the total enzyme releasable by detergent lysis from an equivalent number of cells. In contrast, incubation of C5 with kallikrein, EACA23 cells or trypsin resulted in 45.3, 51.4, and 49.4% ~8-glucuronidase release, respectively. Purified human C5a caused 53.4% release. Thus kallikrein, like EAC423 cells and trypsin, generated from C5 a factor that caused rabbit neutrophils to release a specific granular enzyme.
EFFECT OF CARBOXYPEPTIDASE N. Carboxypeptidase N cleaves the C-terminal arginine from human C5a to generate C5a des arg, a molecular species with 100-fold less secretogogue activity than C5a (9) . To determine whether the chemotactic factor generated from C5 by plasma kallikrein was susceptible to carboxypeptidase N, the following experiment was performed. Kallikrein or trypsin was incubated with C5 under the conditions described above. Human C5a and the rabbit C5-kallikrein and C5-trypsin incubates were treated for 5 min at 22°C with 1 mg SBTI to inhibit the enzymes and then incubated with or without carboxypeptidase N (endopeptidasefree; Worthington Biochemical Corp., Freehold, N. J.), 1% carboxypeptidase N (wt/ wt) in 1% NaHCO3, pH 7.0, for 15 min at 37°C. The ability of human C5a and the C5-kallikrein and C5-trypsin incubates to release fl-glucuronidase in the absence of carboxypeptidase N were 64, 61, and 60% of the total detergent-releasable enzyme, respectively. After incubation with carboxypeptidase N, the respective values were 18, 25, and 16%. Thus, carboxypeptidase N partially inhibited the specific release of flglucuronidase from neutrophils by the kallikrein C5 incubate. Furthermore, the extent of inhibition was similar to that seen for carboxypeptidase-treated human C5a.
CLEAVAGE FRAGMENTS OF C5 GENERATED BY KALLIKREIN.
Studies were performed to determine the size of cleavage fragments generated from C5 by incubation with kallikrein. Fragments of C5 were visualized by both Coomassie Blue staining and autoradiography of 125I-C5 before and after incubation with kallikrein. Analysis of the cleaved proteins in the presence and absence of reducing agents was performed on exponential gradient (8-20%) acrylamide gels in the presence of SDS. In the absence of reducing agents, a single cleavage fragment was consistently seen by autoradiography with an apparent molecular weight of ~14,000. In the presence of reducing agents, only the a-chain of rabbit C5 appeared to be cleaved when analysed both by autoradiography and stained gels. In the presence of reducing agents, fragments were observed with apparent molecular weights of 50,000, 34,000, and 25,000 in addition to the 14,000-Mr fragment.
These findings indicate that plasma kallikrein can release a 14,000-Mr fragment from C5 and that the C5 molecule may also be cleaved by kallikrein at additional sites. The 14,000-Mr fragment could be a chemotactic C5a-like molecule.
Generation of Chemotactic Activity in Kaolin-activated Plasma. Addition of kaolin to plasma results in activation of the HF system with consequent kallikrein activation. Previous studies have reported both that chemotactic activity is (4) or is not (18) generated during kaolin activation of plasma. To resolve this discrepancy, rabbit plasma (containing 0.38% sodium citrate) was activated with kaolin (10 mg/ml final concentration, 10-min incubation at 37°C) under conditions that activate >70% of PK to kallikrein. As a negative control, citrated plasma was used, and as a positive control, citrated plasma was activated with zymosan. Each plasma was assayed for chemotactic activity in triplicate. The results are shown in Table IV . Although there was a consistent trend for kaolin-activated plasma to contain more chemotactic activity than control plasma, this was only statistically significant when low concentrations of plasma were used. These results and other studies consistently indicated that kaolin-activated plasma tends to contain more chemotactic activity than control plasma but much less chemotactic activity than zymosan-activated plasma. However, when kaolin was added to zymosan-activated rabbit plasma at a final concentration of 50 mg/ml, the chemotactic activity was reduced from 58.7 :t: 10.3 to 3.5 zt: 1.6 (n --3, P < 0.01). Thus, at high concentrations kaolin blocks detectable chemotactic activity, probably by binding positively charged C5a to the negatively charged kaolin surface.
Therefore, although the assessment of chemotactic activity in kaolin-activated plasma is complicated by the probable binding of C5a to kaolin, the chemotactic activity of plasma did appear to increase after incubation with kaolin.
Discussion
Previous studies using partially purified preparations of human plasma kallikrein have indicated that kallikrein itself might be directly chemotactic for neutrophils (4, (19) (20) (21) . This observation is surprising, because no other enzyme is known to have direct chemotactic activity. In particular, trypsin, with its ability to hydrolyse peptide Chemotactic activity present in plasmas after incubation alone or with kaolin (5 mg/ml) or zymosan (5 mg/ml) for 10 rain at 37°C. Each sample was tested in triplicate as described in Materials and Methods. Section marks indicate indicate the degree of significance between the treated and control plasmas as indicated by a paired t test. * High power field. 1: P < 0.05. §P< 0.01. bonds adjacent to positively charged residues in a rather unrestricted fashion, is not itself chemotactic. This contrasts with the fact that the trypsinlike arginine esterase plasma kallikrein appeared to require enzymatic activity for its chemotactic activity (4) .
The findings from this study, using highly purified and well characterized proteins and cells of rabbit origin, indicate that rabbit plasma kallikrein is not chemotactic. In addition, HF, HFa, high-Mr kininogen, activated high-Mr kininogen, and PK were not chemotactic alone or when incubated together so that activation occurred in the incubation mixture. Thus, activation of the purified proteins of the HF system did not generate a chemotactic fragment that was detectable under the conditions employed in this study.
However, plasma kallikrein was capable of producing a chemotactic effect if C5 was included in the incubation mixture. Plasma kallikrein at concentrations as low as 1 #g/ml appeared to be capable of generating a chemotactic effect from C5 when the latter was present at physiological concentrations (100 #g/ml). It is unlikely that this effect was due to a contaminating protease that was not detected in the kallikrein preparation by SDS or alkaline gel analysis, because specific anti-kallikrein IgG inhibited kallikrein-mediated kinin generation and kallikrein-mediated chemotaxis ~o a similar extent. The finding that the antibody only partially inhibited both effects provides stronger evidence that the same enzyme was involved. Furthermore, SBTI also inhibited the kinin-generating, chemotactic, and tripeptide-hydrolysing effects to the same extent. We conclude that the chemotaxis generation was due to the action of plasma kallikrein on C5.
The nature of the chemotactic substance generated from C5 by kallikrein appeared to be similar to C5a. Thus, it was chemotactic, it stimulated fl-glucuronidase release from cytochalasin B-treated neutrophils, it was sensitive to carboxypeptidase N digestion, and its activity was associated with the generation of a low-Mr fragment (-14,000) from C5. In addition, the amount ofchemotactic and secretagogue activity generated from C5 by kallikrein was consistent with calculations of the amount of C5a activity that could be released from the quantity of C5 in the initial incubation mixture. Furthermore, kallikrein, like trypsin, is an arginine esterase and the Cterminal amino acid of both human and porcine C5a is arginine (22) . From the above considerations, it seems likely that C5a can be released from rabbit C5 by plasma kallikrein.
The potential importance of kallikrein in liberating CSa from C5 in vivo is not yet known. However, during tissue injury, substances such as bacterial lipopolysaccharides (23), collagen and elastin (24) (25) (26) , basement membrane (27) , and sodium urate and pyrophosphate crystals (28) may act as negatively charged surfaces upon which assembly and activation of the molecules of the HF system can occur (29) . Damaged endothelial cells contain an enzyme capable of directly activating HF (12) . Under these conditions, kallikrein could be generated that might then release C5a from C5. The importance of the capacity of C5a to bind to negatively charged substances, thereby creating a stable surface-bound gradient for orientation of migrating neutrophils, has previously been emphasized (30) . Thus, it is not surprising that negatively charged agents, such as kaolin, used to activate the HF system in the laboratory, should also have the capacity to bind C5a. Although this fact makes the measurement of CSa in the presence of a kallikrein-generating system in plasma more difficult, it may reflect the importance of exposure of negatively charged substances such as basement membrane, collagen, or elastin during tissue injury. It is possible that these negatively charged substances may not only allow activation of the HF system with kallikrein generation, but may also bind C5a locally generated by kallikrein with consequent effects on vascular permeability and attraction of two major effector cells of inflammation: neutrophils and macrophages (31) (32) (33) (34) .
There remains the apparent discrepancy between the findings described in this study using rabbit proteins and previous observations using human proteins (4, (19) (20) (21) . One possible explanation for this discrepancy would be that human leukocytes have a membrane-associated C5-9 complex (35) . Human kallikrein might therefore release C5a from membrane-bound C5 and thus appear to be chemotactic in the assay system. It is possible that the concentrations of rabbit kallikrein used in this study were not sufficient to observe this effect with rabbit leukocytes.
Summary
Rabbit plasma kallikrein incubated with rabbit C5 resulted in the generation of chemotactic and secretagogue activity for rabbit neutrophils. This effect on C5 appeared to be due to kallikrein itself and not to a contaminating enzyme, because it could be inhibited by anti-kallikrein IgG or by soybean trypsin inhibitor to the same extent that kinin generation by the same kallikrein preparation was inhibited by these agents. The chemotactic response was consistent with the generation of a C5a-like peptide from C5 because the effect could be partially inhibited by carboxypeptidase N and was related to the generation of a small (~ 14,000 mol wt) fragment of C5.
No direct chemotactic response was detectable for kallikrein, activated Hageman factor, high-molecular weight kininogen, or intact C5. Incubation of kallikrein, highmolecular weight kininogen, and Hageman factor together, so that activation of all three proteins occurred, did not result in the generation of detectable chemotactic activity.
